2014 PLP 1125 (CLD)
SANOFI-SYNTHELABO through Authorized Signatory — Plaintiff Versus ZAFA PHARMACEUTICAL LABORATORIES (PRIVATE) LIMITED through Chief Executive/ Director/Secretary/Principal Officer — Defendant
| Citation | 2014 PLP 1125 (CLD) |
| Forum / Court | Sindh |
| Bench Members | N/A |
| Parties | SANOFI-SYNTHELABO through Authorized Signatory — Plaintiff Versus ZAFA PHARMACEUTICAL LABORATORIES (PRIVATE) LIMITED through Chief Executive/ Director/Secretary/Principal Officer — Defendant |
| Primary Law | Patents and Designs Act (II of 1911) |
Q1: What are the key laws and sections cited in 2014 PLP 1125 (CLD)?
This judgment primarily cites: Patents and Designs Act (II of 1911) as referenced in Pakistani case law index.
Q2: Which judicial bench decided the case 2014 PLP 1125 (CLD)?
The case was heard and decided by the Sindh bench comprising: N/A.
Q3: What is the official citation format for this judgment on Pakistan Law Portal?
Cite this legal precedent as: 2014 PLP 1125 (CLD) (SANOFI-SYNTHELABO through Authorized Signatory — Plaintiff Versus ZAFA PHARMACEUTICAL LABORATORIES (PRIVATE) LIMITED through Chief Executive/ Director/Secretary/Principal Officer — Defendant). Read the full summary and cross-referenced laws free on Pakistan Law Portal.
Laws Cited
Headnotes / Summary
S. 11
Patents Ordinance (LXI of 2000), S.29
Suit for perpetual injunction to restrain such infringement
Original jurisdiction of High Court
Effect on pending proceedings
Plaintiff had sought relief to the effect that defendant, be prohibited to sell "Clopidogrel" in addition to any other pharmaceutical ingredients/element or compound
Contention of the defendant was that the plaintiff had no cause of action, as the term of patent of the plaintiff had already expired and allegation of infringement of the patent levelled against the defendant was prima facie without any evidence
Suit became infructuous in the month of May, 2014
On the instruction of the plaintiff, counsel for the plaintiff stated that instructions had been taken from the plaintiff and since the term of the patent shall, in any case, expire by the end of May, 2014, therefore, suit itself shall be withdrawn
Suit had become infructuous and no purpose could be achieved by any of the parties by keeping this matter pending in court without any reason, therefore, the suit could not be kept pending and was required to be disposed of in pursuance of the 'concept of abatement'
Suit of the plaintiff was disposed of as having become infructuous along with applications.
Judgment & Decree
AAMIR RAZA NAQVI, J.
This suit was filed for a relief to the effect that sale of Clopidogrel be prohibited by defendant in addition to any other pharmaceutical ingredients/element or compound. There were other similar reliefs as well. The written statement was filed in the matter and following preliminary legal objections were raised:-- (1) That the Suit is misconceived, frivolous, and without cause of action. As the patent of the plaintiff has already expired on 16-2-2003 under section 11 of Patents and Designs Act, 1911 and section 29 of the Patents Ordinance, 2000, the same having been registered as Patent in France on February 17 1987, clause 2 of the Paris Convention published by World Intellectual Property Organization (WIPO) publication No. 4000(E) of which Pakistan is the signatory. (2) That the plaintiff's allegations against the defendant of infringement of the Patent is prima facie without any evidence. As the matter of fact the defendants are not manufacturing any medicine/drug of Clopidogrel nor they have imported Clopidogrel manufactured by the plaintiff. The allegations are based purely on presumptions. (3) That Clopidogrel is produced/manufactured by other Pharmaceutical Companies under their own invention, formula, device and import of the same by anyone in Pakistan is not restricted/prohibited under the Patents Ordinance (LXI of 2000). So the suit is without cause of action. Thereafter suit was being proceeded and listed applications remained pending for considerable time, it is also fixed for examination of parties/settlement of issues. The order dated 23-1-2014 shows that both the learned counsel were conscious of the fact that in the month of May, 2014 the suit would become infructuous and it was ordered that suit be taken up thereafter. For such purpose, learned counsel for the parties sought time to take instructions and matter was adjourned to 11-2-2014. On such date, the matter was again adjourned to 25-2-2014 by consent. On 25-2-2014 learned counsel for the plaintiff stated that instructions have been taken from the plaintiff and since the terms of patent shall, in any case, expire by the end of May, 2014, therefore suit itself shall be withdrawn. In the same order, it was also observed that from 1st June, 2014 interim orders shall automatically stand recalled and vacated without any order being required by the Court. After such date plaintiff stopped appearing in the matter despite the fact that notices were repeated. In view of above facts and circumstances, it appears that this suit has become infructuous and no purpose can be achieved by any of the parties by keeping this matter pending in Court without any reason. In view of this, this suit cannot be kept pending and is required to be disposed. In the circumstances, mentioned above, it is an appropriate case in which following the theory of abatement suit should be ordered to have abated. Reliance is placed in the case of Mubashir Muhammad Khan v. Government of Pakistan and others (1992 SCMR 866), in the judgment of said case the concept of abatement has been referred in para-5-A at page-870. In view of above, this suit is disposed of as having been infructuous along with listed applications. SA/S-51/Sindh Order accordingly.